112 related articles for article (PubMed ID: 2564410)
1. [Clinical usefulness of serum sialyl Le(x)-i measurement in patients with ovarian cancer].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):15-9. PubMed ID: 2564410
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients].
Tanaka T; Iwasaka T; Hayashi Y; Hachisuga T; Yokoyama M; Ohkuma Y; Matsuo N; Fukuda K; Sugimori H
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1157-61. PubMed ID: 1975831
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
[TBL] [Abstract][Full Text] [Related]
5. [The clinical value of sialyl SSEA-1 antigen in patients with gynecologic tumors].
Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saitoh J; Ueda G; Tanizawa O; Kimura T; Kawata M; Taniguchi T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2120-4. PubMed ID: 2892886
[TBL] [Abstract][Full Text] [Related]
6. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
[TBL] [Abstract][Full Text] [Related]
7. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):828-34. PubMed ID: 3166483
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
9. [Cancer-associated carbohydrate antigens available for serum diagnosis].
Sawabu N; Takemori Y; Satomura Y; Watanabe H; Kawakami H; Hattori N
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1091-101. PubMed ID: 2898921
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease.
Iwanari O; Miyako J; Date Y; Nakayama S; Kijima S; Moriyama M; Karino K; Endoh J; Kitao M
Gynecol Obstet Invest; 1990; 29(3):214-8. PubMed ID: 1972688
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum sialyl SSEA-1 antigen levels in patients with epithelial ovarian cancer. Comparative effectiveness of sialyl SSEA-1 and CA 125.
Kobayashi H; Kawashima Y
Gynecol Obstet Invest; 1990; 30(1):52-8. PubMed ID: 1977666
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers].
Kawakami H; Sawabu N; Takemori Y; Okai T; Motoo Y; Satomura Y; Ohta H; Watanabe H; Matsuda N; Yamakawa O
Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1141-8. PubMed ID: 2571740
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer.
Suzuki M; Ohwada M; Tamada T
Gynecol Oncol; 1990 Mar; 36(3):371-5. PubMed ID: 1969379
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
[TBL] [Abstract][Full Text] [Related]
18. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
[TBL] [Abstract][Full Text] [Related]
19. [Ectopic expression of carbohydrate antigens that determine the metastatic potential of human colorectal carcinoma].
Irimura T
Gan To Kagaku Ryoho; 1993 Feb; 20(3):373-9. PubMed ID: 8094951
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of serum sialyl Lewis X-i (SLX) in diffuse panbronchiolitis].
Noguchi M; Nakatani T; Chohnabayashi N; Nakamori Y; Nakata K; Matsushita H; Tanimoto H
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):317-25. PubMed ID: 2575680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]